Nipah virus (NiV) is a zoonotic RNA virus belonging to the Paramyxoviridae family, characterized by high lethality and potential pandemic risk. The following is a systematic overview of its key information:

---

1. Discovery and Distribution

· First outbreak: 1998 in Baling, Negeri Sembilan, Malaysia (initially identified in pig farms, with most infected individuals having close contact with pigs).
· Name origin: From "Kampung Sungai Nipah" in Malaysia.
· Main endemic areas: Southeast Asia (Malaysia, Singapore, Bangladesh, India), with recent cases reported in the Philippines.

---

2. Natural Hosts and Transmission Routes

· Natural hosts: Fruit bats (family Pteropodidae), especially larger frugivorous bats, asymptomatic carriers that harbor the virus long-term.
· Transmission routes:
· Animal-to-human: Contact with secretions/excretions of infected animals (such as pigs, horses), or consumption of food contaminated by bats (e.g., date palm sap, fruits).
· Human-to-human: Close contact with respiratory secretions, saliva, or body fluids of infected persons (common in outbreaks in Bangladesh and India).
· Environmental: Contact with environments contaminated by bat urine or saliva.

---

3. Clinical Manifestations

· Incubation period: Usually 4-14 days, up to 45 days.
· Range of symptoms: From asymptomatic infection to fatal encephalitis.
· Early: Fever, headache, myalgia, vomiting, sore throat.
· Severe: Encephalitis (drowsiness, confusion, seizures, coma), some patients develop acute respiratory distress syndrome.
· Sequelae: About 20% of survivors experience neurological deficits (personality changes, persistent seizures, etc.).

---

4. Diagnosis and Treatment

· Diagnosis:
· Real-time RT-PCR detection of viral RNA (blood, cerebrospinal fluid, respiratory secretions).
· Serological tests (ELISA for IgG/IgM antibodies).
· Virus isolation (requires BSL-4 laboratory).
· Treatment:
· No specific antiviral drugs or vaccines available (as of 2024, candidate vaccines are in clinical trials).
· Supportive care: respiratory support, hydration, management of complications.
· Monoclonal antibody (m102.4) has been used compassionately in emergencies; efficacy requires further validation.

---

5. Prevention and Control

· Avoid contact with sources of infection:
· Do not consume raw fruits or vegetables contaminated by bats or unboiled date palm juice.
· Monitor and isolate animals (pigs, horses) in endemic areas.
· Infection control:
· Isolate patients; healthcare workers must strictly follow protective measures (masks, gloves, goggles).
· Proper handling of deceased individuals (direct contact with corpses can lead to infection).
· Public health measures:
· Strengthen surveillance and early warning systems (especially in high-risk areas).
· Increase community awareness of transmission routes.

---

6. Potential Risks and Challenges

· High lethality: Case fatality rate approximately 40%-75% (depending on viral strain and healthcare conditions).
· Human-to-human transmission capability: Although requiring close contact, outbreaks in areas with poor healthcare infrastructure can lead to cluster infections.
· Viral mutation risk: As an RNA virus, it may mutate to enhance transmissibility or virulence.
· Biosafety level: Classified as BSL-4 pathogen, requiring maximum containment for research.

---

Global Attention and Response

The World Health Organization (WHO) has listed Nipah virus as a priority pathogen (alongside Ebola and Zika), aiming to accelerate vaccine and drug development. International collaborations (such as CEPI funding vaccine research) are advancing preparedness and control efforts.

---

Summary

Nipah virus is a bat-origin pathogen with high lethality and pandemic potential, currently lacking specific therapies. Prevention relies on early detection, blocking animal-to-human and human-to-human transmission chains, and public health education. Ongoing research into vaccines and antiviral drugs is critical for future outbreak preparedness.

If more specific details are needed (such as historical outbreak cases, latest scientific advances, etc.), further information can be provided.